ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Archive ouverte

Lemarchant, Sighild | Pruvost, Mathilde | Montaner, Joan | Emery, Evelyne | Vivien, Denis | Kanninen, Katja | Koistinaho, Jari

Edité par CCSD ; BioMed Central -

International audience. : ADAMTS-1, -4, -5 and -9 belong to 'a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)' family and more precisely to the proteoglycanases subgroup based on their common ability to degrade chondroitin sulfate proteoglycans. They have been extensively investigated for their involvement in inflammation-induced osteoarthritis, and a growing body of evidence indicates that they may be of key importance in the physiological and pathological central nervous system (CNS). In this review, we discuss the deregulated expression of ADAMTS proteoglycanases during acute CNS injuries, such as stroke and spinal cord injury. Then, we provide new insights on ADAMTS proteoglycanases mediating synaptic plasticity, neurorepair, angiogenesis and inflammation mechanisms. Altogether, this review allows us to propose that ADAMTS proteoglycanases may be original therapeutic targets for CNS injuries.

Suggestions

Du même auteur

tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury

Archive ouverte | Lemarchant, Sighild | CCSD

International audience

Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer’s Disease

Archive ouverte | Vellonen, Kati-Sisko | CCSD

International audience. PURPOSE: Alzheimer's disease (AD) may disturb functions of the blood-brain barrier and change the disposition of drugs to the brain. This study assessed the disease-induced changes in drug tr...

Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.

Archive ouverte | Roussel, Benoit, D | CCSD

International audience. Recombinant tissue-type plasminogen activator (tPA) is the fibrinolytic drug of choice to treat stroke patients. However, a growing body of evidence indicates that besides its beneficial thro...

Chargement des enrichissements...